scispace - formally typeset
K

Katarina Kralova

Researcher at Comenius University in Bratislava

Publications -  129
Citations -  2364

Katarina Kralova is an academic researcher from Comenius University in Bratislava. The author has contributed to research in topics: Antimycobacterial & Lipophilicity. The author has an hindex of 27, co-authored 115 publications receiving 2025 citations. Previous affiliations of Katarina Kralova include Charles University in Prague & Cork Institute of Technology.

Papers
More filters
Journal ArticleDOI

Potential of Nanonutraceuticals in Increasing Immunity

TL;DR: This contribution summarizes the current state of the research and development of effective nanonutraceuticals influencing the body’s immune responses, such as vitamins, minerals, antioxidants, omega-3 fatty acids, and probiotics.
Journal ArticleDOI

The effect of Cu(II) ions bound with tridentate Schiff base ligands upon the photosynthetic apparatus

TL;DR: In this article, the effect of diaqua-(N-pyruvidene-β-alaninato) copper (II) monohydrate (Cu(pyr-β)-ala)) on the photosynthetic apparatus of spinach chloroplasts was investigated.
Journal ArticleDOI

Activity of ring-substituted 8-hydroxyquinoline-2-carboxanilides against intestinal sulfate-reducing bacteria Desulfovibrio piger

TL;DR: The antibacterial efficacy of the most active C’(3)-substituted compounds practically did not change with increasing compound lipophilicity, indicating that this position of substitution is favorable for significant antimicrobial effect.
Journal ArticleDOI

Ring-substituted 8-hydroxyquinoline-2-carboxanilides as potential antimycobacterial agents.

TL;DR: In this study, a series of twenty-two ring-substituted 8-hydroxyquinoline-2-carboxanilides was prepared and characterized and some of the tested compounds showed the antimycobacterial activity against M. paratuberculosis comparable with or higher than that of rifampicin.
Book ChapterDOI

Application of Nanobioformulations for Controlled Release and Targeted Biodistribution of Drugs

TL;DR: In this paper, the authors focus on natural-based biocompatible and biodegradable materials that are used as matrices/carriers for controlled release or targeted biodistribution of nanoscale active pharmaceutical ingredients with low toxicity and favorable pharmacokinetics.